Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 15, Number 14, May 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

Editorial [Hot Topic: New Antidepressant Drugs: Beyond Monoaminergic Mechanisms (Executive Editors: Cecilio Alamo and Francisco Lopez-Munoz)]
pp. 1559-1562(4)
Authors: Alamo, Cecilio; Lopez-Munoz, Francisco

Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today
pp. 1563-1586(24)
Authors: Lopez-Munoz, Francisco; Alamo, Cecilio

CRF Receptors as a Potential Target in the Development of Novel Pharmacotherapies for Depression
pp. 1587-1594(8)
Author: Valdez, Glenn R.

Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
pp. 1595-1611(17)
Authors: Machado-Vieira, Rodrigo; Salvadore, Giacomo; Ibrahim, Lobna A.; Diaz-Granados, Nancy; Zarate Jr., Carlos A.

Opiates as Antidepressants
pp. 1612-1622(11)
Authors: Berrocoso, Esther; Sanchez-Blazquez, Pilar; Garzon, Javier; Mico, Juan A.

Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models
pp. 1623-1646(24)
Authors: Rodriguez Bambico, Francis; Duranti, Andrea; Tontini, Andrea; Tarzia, Giorgio; Gobbi, Gabriella

Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
pp. 1647-1674(28)
Authors: Ebner, Karl; Sartori, Simone B.; Singewald, Nicolas

Melatonin Receptor Agonist Agomelatine: A New Drug for Treating Unipolar Depression
pp. 1675-1682(8)
Authors: Bourin, Michel; Prica, Corina

New Approaches to Antidepressant Drug Design: Cytokine-Regulated Pathways
pp. 1683-1687(5)
Authors: Nishida, Akira; Miyaoka, Tsuyoshi; Inagaki, Takuji; Horiguchi, Jun

Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs
pp. 1688-1698(11)
Author: Zhang, Han-Ting

Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions
pp. 1699-1708(10)
Authors: Golan, Moran; Schreiber, Gabriel; Avissar, Sofia

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A